iOnctura achieves new clinical milestones in uveal melanoma therapy - PharmaTimes Successful phase 1 study highlights potential of roginolisib

#iOnctura #uvealmelanoma #uvealmelanomapatients #uvealmelanomatherapy #phase1study #roginolisib #phase1#DIONE01study #clinicalactivity #longtermsafety #ESMO #EuropeanSocietyforMedicalOncology #ImmunoOncology #allostericbindingmechanism #phase2study #OCULE01study
pharmatimes.com/news/ionctur...